Navigation Links
The Conference Forum Launches 1st Dedicated Biotech Chief Medical Officer Newsletter

The Conference Forum is pleased to announce the launch of Chief Medical Officer 360°, the first newsletter solely dedicated to the unique role of the Chief Medical Officer in the biotech industry. The newsletter will capture a wide range of perspectives on the responsibilities, problem-solving, best practices and career development of CMOs and Heads of R&D from different therapeutic areas in the US and around the world. Physician scientists and others serving in biotech will also benefit from the expertise of leaders in the community.

“Chief Medical Officers are responsible for a vast number of R&D functions and we are excited to publish a quarterly newsletter specifically for this community,” said Andrew Goldstein, Editor of Chief Medical Officer 360°.

The inaugural issue will feature the following topics: the evolving role of the CMO through IPO; incorporating the patient perspective; enterprise management; developing treatments for SARS-CoV-2; advice for R&D leaders in challenging times; and partnering effectively with CROs. The issue ends with a recap from the archive: a session from the 2017 Chief Medical Officer Summit on How R&D Leadership Can Work More Collaboratively with Investors.

“CMOs are first and foremost responsible for patient safety and drive all R&D functions while supporting the CEO. We want to build more resources to help the CMO community interact and share peer-to-peer best practices,” said Valerie Bowling, Executive Director, the Conference Forum.

The following CMOs are featured in the inaugural issue: Dr Dana Hilt, CMO, Frequency Therapeutics, Dr Barry Ticho, CMO, Stoke Therapeutics, Dr Nerissa Kreher, CMO, Tiburio Therapeutics, Dr Beth Trehu, CMO, Jounce Therapeutics, Dr Akshay Vaishnaw, President, R&D, Alnylam, Dr Francisco Diaz-Mitoma, CMO, VBI Vaccines, and Dr Daniel Burch, Global Head, PPD Biotech.

The Conference Forum also presents the Chief Medical Officer Summit 360° two-day event and CMO-related podcasts. With the conferences, podcasts and quarterly newsletters, the company provides helpful insights and ongoing support for the CMO and R&D leadership community.

About the Conference Forum:
The Conference Forum is a research firm and develops specialized content for professionals in the life science and healthcare industries. The company currently offers conferences and newsletters for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and non-profit/government healthcare groups. The Conference Forum's mission is to create the best content, facilitate the exchange of ideas and provide quality networking to help move therapeutics to patients faster. Learn more about The Conference Forum at

Read the full story at

Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved

Related biology technology :

1. Senomyx To Webcast Corporate Presentation At The 25th Annual ROTH Conference
2. Annual Conference about Technology Solutions for People with Disabilities Announces Program
3. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
5. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
6. Palatin Technologies To Present At The 25th Annual ROTH Conference
7. 3D Biomatrix Announces Stipend to Present at Spring 2013 Conferences
8. NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
9. New Applications of Pressure BioSciences PCT Platform Prominently Featured at Scientific Conference on Technologies for Protein Research
10. Life Sciences Technology Conference and Career Fair on March 26th in Raleigh, NC
11. Neogen Corporation Announces 3rd Quarter Results Conference Call
Post Your Comments:
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra , ... sciences and food industries, is pleased to announce that Charles Galea has joined ... Development. , Charles is an accomplished and results-driven sales executive with over 10 ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... ... June 29, 2020 , ... The ... purchasing contracts to its membership, recently named BioFit Engineered Products an ... opportunity to purchase ergonomic seating, cafeteria tables, book trucks and carts at discounted ...
(Date:6/28/2020)... HILL, Conn. (PRWEB) , ... June 25, 2020 ... ... company formed to advance photodynamic therapy for treating cancer, today announced the company ... New York (“Roswell Park”). The agreement provides Lumeda globally exclusive rights to ...
Breaking Biology Technology:
(Date:6/28/2020)... ... 2020 , ... In an upcoming episode scheduled for the fall of 2020, ... solutions (POCT). Check local listings for more info. , Today, the majority of testing ... to labs throughout the country. Results are then available several days later. Now, in ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... to announce the next event in a series of TOPIQ webinars, which will ... series of webinars was developed in response to social distancing measures that resulted ...
(Date:6/13/2020)... ... 2020 , ... Bode Technology (Bode), a leading ... team. Bode’s Forensic Genealogy Service (FGS) continues to deliver investigative leads ... The team has added experienced genealogists, each having over a decade of field ...
Breaking Biology News(10 mins):